Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

181 trials

NCT06309251
Recruiting
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Not applicable · Italy · 3 sites
Registry update: 3 Sept 2025
NCT05156398
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · Canada, Spain, France, Italy, Japan, Poland, United States · 106 sites
Registry update: 14 Oct 2026
NCT05125302
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Phase 3 · Puerto Rico, United States · 129 sites
Registry update: 14 Sept 2026
NCT06219694
Recruiting
Laser Acupuncture for Chronic Migraine
Not applicable · Taiwan · 1 site
Registry update: 20 Nov 2025
NCT04151472
Recruiting
Idebenone for the Preventive Treatment of Migraine
Phase 3 · China · 1 site
Registry update: 15 May 2025
NCT05164172
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Phase 3 · Argentina, Canada, Spain, United Kingdom, Italy, Mexico, Poland, Portugal, Serbia, United States · 71 sites
Registry update: 14 Oct 2026
NCT05046613
Recruiting
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Not applicable · United States · 1 site
Registry update: 29 Oct 2026
NCT05418218
Recruiting
International Headache Registry Study
Not applicable · China · 1 site
Registry update: 23 May 2025
NCT04965675
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Phase 3 · Argentina, Canada, Spain, United Kingdom, Italy, Mexico, Poland, Portugal, Serbia, United States · 82 sites
Registry update: 16 Oct 2026
Conflicting statuses (updated in the registry within the last month)
NCT04743141
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · Spain, Poland, United States · 121 sites
Registry update: 27 Oct 2026
NCT07163416
Recruiting
(Italian Migraine Registry, I-GRAINE-NEW)
Not applicable · Italy · 1 site
Registry update: 20 Oct 2026
NCT04748601
Recruiting
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Phase 4 · United States · 15 sites
Registry update: 27 Jan 2025
NCT06150781
Recruiting
Aimovig Pregnancy Exposure Registry
Not applicable · United States · 1 site
Registry update: 4 Nov 2025
NCT04649242
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · Canada, China, Spain, United Kingdom, Japan, Mexico, Poland, Sweden, United States · 236 sites
Registry update: 27 Oct 2026
NCT04686253
Recruiting
Internal Microstructure of Patent Foramen Ovale Related to Stroke
Not applicable · China · 2 sites
Registry update: 22 Jul 2025
NCT04628429
Recruiting
CGRP Inhibition, Autonomic Function, and Migraine
Not applicable · Austria · 1 site
Registry update: 10 Dec 2024
NCT04063540
Recruiting
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
Phase 2 · France · 5 sites
Registry update: 4 Dec 2025
NCT03694626
Recruiting
Objectively Diagnose and Monitor Treatment of Light Sensitivity
Not applicable · United States · 1 site
Registry update: 8 Sept 2026
NCT03404336
Recruiting
Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy
Not applicable · Italy · 2 sites
Registry update: 5 May 2026
NCT04939922
Recruiting
China Headache and Vertigo Registry Study
Not applicable · China · 1 site
Registry update: 25 Jul 2025

Ordered by registry start date. Freshness and sponsorship never change the order.